Search
Use the filters to narrow by type of content
Looking for a Publication? Search the bibliography for: publications epidemiology burden complex perianal fistulas patients crohns disease– systematic
… session, Dr. Garcia de Albeniz Martinez, Director of Epidemiology at RTI Health Solutions, will share his …
… treatments, adverse events, and the overall survival of patients with chronic lymphocytic leukemia (CLL) and mantle … led to gaps in evidence —evidence needed to understand the burden of these blood cancers more fully. To provide detailed … The annual economic burden of adverse events and other disease-related medical costs of CLL alone in the United …
… - Perform mapping to derive EQ-5D utility estimates from a disease-specific measure - Develop a health preference index from a disease-specific PRO instrument - Conduct health preference … such as NICE, SMC, CDR, and PBAC), value messaging , and publications A Team Approach Let our multidisciplinary team …
… and promote engagement and collaboration with patients, industry, academia, and consumers. Visit the …
… data collection—including cohort studies and surveys of patients, physicians, or caregivers. Prospective … studies can help you: Understand the natural history of a disease and its treatment Quantify and characterize product … intervention Understand outcomes from the perspective of patients, physicians, and caregivers Evaluate risk management …
… 15th Clinical Trials on Alzheimer's Disease (CTAD) Share on: Tuesday, November 29 - Friday, … be presented at the 15th Clinical Trials on Alzheimer's Disease. Economic burden of daily transitions to later stages of AD dementia in …
… a Critical Element in the Search for Alzheimer’s Disease Treatments Share on: June 16, 2021 Image What Matters Most to Patients and Caregivers Dana DiBenedetti, PhD Executive … effects that Alzheimer’s Disease (AD) has on both patients and families are sadly well established. As …
… do you know which of those attributes matter most to your patients? As a stated-preference method, discrete-choice … are relative based on a person’s understanding of their disease state, disease progression, and available therapies, so market …
… MSBase Registry: Comparing Natalizumab to Fingolimod in Patients with Inadequate Response to Disease-Modifying Therapies in Relapsing-Remitting Multiple … associated with a significant humanistic and economic burden. While there is no cure for MS, disease-modifying …
… of high-dose versus standard-dose influenza vaccination in patients with end-stage renal disease Layton JB , McGrath LJ, Sahrmann JM, Ma Y, … like dialysis sessions or physician visits. In medically complex populations with predictable patterns of healthcare …